product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-MAPKAPK-2 (Thr334) Antibody
catalog :
3041
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section, proximity ligation assay
citations: 10
Published Application/Species/Sample/DilutionReference
  • western blot; rat; fig 6
Namachivayam K, Mohankumar K, Arbach D, Jagadeeswaran R, Jain S, Natarajan V, et al. All-Trans Retinoic Acid Induces TGF-β2 in Intestinal Epithelial Cells via RhoA- and p38α MAPK-Mediated Activation of the Transcription Factor ATF2. PLoS ONE. 2015;10:e0134003 pubmed publisher
  • proximity ligation assay; mouse; 1:200; fig 3
  • immunohistochemistry - frozen section; mouse; 1:50; fig 3
Hausburg M, Doles J, Clement S, Cadwallader A, Hall M, Blackshear P, et al. Post-transcriptional regulation of satellite cell quiescence by TTP-mediated mRNA decay. elife. 2015;4:e03390 pubmed publisher
  • western blot; human
Kemp M, Lindsey Boltz L, Sancar A. UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1). J Biol Chem. 2015;290:12184-94 pubmed publisher
  • western blot; mouse; 1:1000
Lee S, Xu G, Jay T, Bhatta S, Kim K, Jung S, et al. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J Neurosci. 2014;34:12538-46 pubmed publisher
  • western blot; human
Willemen H, Campos P, Lucas E, Morreale A, Gil Redondo R, Agut J, et al. A novel p38 MAPK docking-groove-targeted compound is a potent inhibitor of inflammatory hyperalgesia. Biochem J. 2014;459:427-39 pubmed publisher
Wu T, Shi J, Geng S, Zhou W, Shi Y, Su X. The MK2/HuR signaling pathway regulates TNF-?-induced ICAM-1 expression by promoting the stabilization of ICAM-1 mRNA. BMC Pulm Med. 2016;16:84 pubmed publisher
Lei B, Schwinn D, Morris D. Stimulation of ?1a adrenergic receptors induces cellular proliferation or antiproliferative hypertrophy dependent solely on agonist concentration. PLoS ONE. 2013;8:e72430 pubmed publisher
Menon M, Kotlyarov A, Gaestel M. SB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition. PLoS ONE. 2011;6:e23054 pubmed publisher
Chang E, Heo K, Woo C, Lee H, Le N, Thomas T, et al. MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation. Blood. 2011;117:2527-37 pubmed publisher
Lindauer M, Wong J, Magun B. Ricin Toxin Activates the NALP3 Inflammasome. Toxins (Basel). 2010;2:1500-1514 pubmed
product information
SKU :
3041S
Product-Name :
Phospho-MAPKAPK-2 (Thr334) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
49
Host :
Rabbit
Target :
MAPKAPK-2 (Thr334) phosphate
Primary-Protein :
MAPKAPK2
Alt-Names :
MAP kinase-activated protein kinase 2,MAPK-activated protein kinase 2,MAPK2,MAPKAP kinase 2,MAPKAPK-2,MAPKAPK2,MK2,mitogen-activated protein kinase-activated protein kinase 2
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.